High Mobility Group Box 1 Inhibition by Antisense Oligonucleotide Attenuates Angiotensin II-induced Abdominal Aortic Aneurysm

Bibliographic Details
Published in:	JVS - Vascular Science
Main Authors:	Shayan Mohammadmoradi, Hisashi Sawada, Sohei Ito, Adam E. Mullick, Deborah A. Howatt, Michael Franklin, Hong S. Lu, Alan Daugherty
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666350323000652

Similar Items

Doxycycline does not influence established abdominal aortic aneurysms in angiotensin II-infused mice.
by: Xiaojie Xie, et al.
Published: (2012-01-01)

Thermoneutrality Does Not Affect Angiotensin II–Induced Aortic Aneurysms in Hypercholesterolemic Mice
by: Liyuan Zhu, et al.
Published: (2025-10-01)

Imaging Techniques for Aortic Aneurysms and Dissections in Mice: Comparisons of Ex Vivo, In Situ, and Ultrasound Approaches
by: Sohei Ito, et al.
Published: (2022-02-01)

Metformin ameliorates established abdominal aortic aneurysms induced by elastase in mice
by: Hong S. Lu, MD, PhD, et al.
Published: (2023-01-01)

Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
by: Naofumi Amioka, et al.
Published: (2022-06-01)

Abdominal aortic aneurysms: insights into mechanical and extracellular matrix effects from mouse models
by: Hong S. Lu, MD, PhD, et al.
Published: (2023-01-01)

TGF-β Neutralization Enhances AngII-Induced Aortic Rupture and Aneurysm in Both Thoracic and Abdominal Regions.
by: Xiaofeng Chen, et al.
Published: (2016-01-01)

Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice
by: Haruhito A. Uchida, et al.
Published: (2022-08-01)

β-Aminopropionitrile-induced aortic aneurysm and dissection in mice
by: Hisashi Sawada, MD, PhD, et al.
Published: (2022-01-01)

Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
by: Daisuke Ito, et al.
Published: (2024-12-01)

Pharmacokinetics of antisense oligonucleotide drugs
by: M. R. Khaitov, et al.
Published: (2013-04-01)

Tissue pharmacokinetics of antisense oligonucleotides
by: Erica Bäckström, et al.
Published: (2024-03-01)

Tofersen and other antisense oligonucleotides in ALS
by: Albert Ludolph, et al.
Published: (2025-01-01)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
by: Saumya Jani, et al.
Published: (2021-04-01)

Antisense Oligonucleotides: Concepts and Pharmaceutical Applications
by: Ariana Araya, et al.
Published: (2023-02-01)

In-silico study of antisense oligonucleotide antibiotics
by: Erica S. Chen, et al.
Published: (2023-11-01)

β-aminopropionitrile-induced thoracic aortopathy is refractory to cilostazol and sildenafil in mice.
by: Samuel C Tyagi, et al.
Published: (2025-01-01)

β-aminopropionitrile-induced thoracic aortopathy is refractory to cilostazol and sildenafil in mice
by: Samuel C. Tyagi, et al.
Published: (2025-01-01)

Manipulation of components of the renin angiotensin system in renal proximal tubules fails to alter atherosclerosis in hypercholesterolemic mice
by: Masayoshi Kukida, et al.
Published: (2023-08-01)

The expanding application of antisense oligonucleotides to neurodegenerative diseases
by: Charlotte J. Sumner, et al.
Published: (2024-10-01)

Nonviral delivery systems for antisense oligonucleotide therapeutics
by: Si Huang, et al.
Published: (2022-09-01)

Antisense oligonucleotides and their applications in rare neurological diseases
by: Simon McDowall, et al.
Published: (2024-09-01)

Antisense oligonucleotide therapy for KCNT1 encephalopathy
by: Lisseth Estefania Burbano, et al.
Published: (2022-12-01)

The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
by: Maria Gagliardi, et al.
Published: (2021-04-01)

Antisense Oligonucleotide-Based Therapy of Viral Infections
by: Woan-Yuh Tarn, et al.
Published: (2021-11-01)

Antisense Oligonucleotide-Mediated Transcript Knockdown in Zebrafish.
by: Andrea Pauli, et al.
Published: (2015-01-01)

Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms.
by: Aruna Poduri, et al.
Published: (2012-01-01)

Pharmacological Inhibition of Gasdermin D Suppresses Angiotensin II-Induced Experimental Abdominal Aortic Aneurysms
by: Jia Guo, et al.
Published: (2023-05-01)

Melanocortin-4 receptor in macrophages attenuated angiotensin II-induced abdominal aortic aneurysm in mice
by: Kentaro Mori, et al.
Published: (2023-11-01)

Mechanical activation of the angiotensin II type 1 receptor contributes to abdominal aortic aneurysm formation
by: SarahRose Hall, BA, et al.
Published: (2021-01-01)

Antisense oligonucleotides for the arterial hypertension mechanisms study and therapy
by: L. O. Klimov, et al.
Published: (2018-04-01)

Antisense oligonucleotides targeting IRF4 alleviate psoriasis
by: Yanxia Yu, et al.
Published: (2025-07-01)

Antisense oligonucleotides: a novel Frontier in pharmacological strategy
by: D. Collotta, et al.
Published: (2023-11-01)

The Evolution of Antisense Oligonucleotide Chemistry—A Personal Journey
by: Sudhir Agrawal
Published: (2021-05-01)

Antisense oligonucleotides provide optimism to the therapeutic landscape for tauopathies
by: Glenn A. Harris, et al.
Published: (2025-03-01)

Splice-switching antisense oligonucleotides for pediatric neurological disorders
by: Xiaochang Zhang
Published: (2024-07-01)

Progress in the Treatment of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
by: XU Tingting, et al.
Published: (2022-04-01)

Antisense Oligonucleotide-mediated Knockdown in Mammary Tumor Organoids
by: Sarah Diermeier, et al.
Published: (2017-08-01)

Abdominal Aortic Aneurysm
by: Ken Tillman PhD, RN, et al.
Published: (2013-03-01)

CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation
by: Aaron J Donner, et al.
Published: (2015-01-01)